Legal Representation
Attorney
Michelle E. Tochtrop
USPTO Deadlines
Next Deadline
1896 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-10-08)
Due Date
October 08, 2030
Grace Period Ends
April 08, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
May 7, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
May 7, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
May 7, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
May 7, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
May 7, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Apr 4, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Mar 14, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Mar 14, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Jan 8, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Oct 8, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Oct 8, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Sep 14, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
Aug 28, 2024 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
Aug 28, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Jul 23, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jul 23, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 3, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 14, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 12, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 12, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 12, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 7, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Dec 13, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Dec 13, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Dec 6, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Dec 5, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 16, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 7, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Apr 3, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 31, 2023 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | Loading... |
Detailed Classifications
Class 001
Micro-organisms and cultures of micro-organisms, in particular bacteria for use in food manufacture, bifidobacterium probiotic bacteria for use in the manufacture of food supplements, food, medical preparations, yeast nutrients for industrial purposes and fermented milk products in the nature of milk ferments for industrial purposes; micro-organisms and cultures of microorganisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings and reared animal species, not for medical or veterinary use for use in the manufacture of food supplements, food, medical preparations; micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried and freeze-dried form, namely, probiotic bacteria for use in the manufacture of food supplements, food, medical preparations
Class 005
Micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings and to reared animal species, for medical and veterinary use; micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, anallergic bifidobacterium probiotic bacteria which has beneficial activity on the intestinal microflora of babies; proprietary medicine containing micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, bifidobacterium probiotic bacteria for treating the intestinal bacterial flora, for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy, for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora, for treating intestinal dismicrobic syndromes, in particular in diseases linked to changes in the bacterial flora such as diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, to be taken orally, in particular in the form of capsules, tablets, solutions, suspensions, granules and granules in dried or freeze-dried form; food supplements, food supplements for medical use containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings; dietary supplements; food supplements containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings and reared animal species, not for medical or veterinary use; symbiotic dietary supplements containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria and prebiotic fibres; food supplements for animals, not for medical use
Classification
International Classes
001
005